The Impact of Environmental Factors on Monogenic Mendelian Diseases.

dc.contributor.author

Tukker, Anke M

dc.contributor.author

Royal, Charmaine D

dc.contributor.author

Bowman, Aaron B

dc.contributor.author

McAllister, Kimberly A

dc.date.accessioned

2021-04-19T02:53:06Z

dc.date.available

2021-04-19T02:53:06Z

dc.date.issued

2021-03-02

dc.date.updated

2021-04-19T02:53:05Z

dc.description.abstract

Environmental factors and gene-environment interactions modify the variable expressivity, progression, severity, and onset of some classic (monogenic) Mendelian-inherited genetic diseases. Cystic Fibrosis, Huntington Disease, Parkinson's Disease, and Sickle Cell Disease are examples of well-known Mendelian disorders that are influenced by exogenous exposures. Environmental factors may act by direct or indirect mechanisms to modify disease severity, timing, and presentation, including through epigenomic influences, protein misfolding, miRNA alterations, transporter activity, and mitochondrial effects. Since pathological features of early-onset Mendelian diseases can mimic later onset complex diseases, we propose that studies of environmental exposure vulnerabilities using monogenic model systems of rare Mendelian diseases have high potential to provide insight into complex disease phenotypes arising from multi-genetic/multi-toxicant interactions. Mendelian disorders can be modeled by homologous mutations in animal model systems with strong recapitulation of human disease etiology and natural history, providing an important advantage for study of these diseases. Monogenic high penetrant mutations are ideal for toxicant challenge studies with a wide variety of environmental stressors, since background genetic variability may be less able to alter the relatively strong phenotype driving disease-causing mutations. These models promote mechanistic understandings of gene-environment interactions and biological pathways relevant to both Mendelian and related sporadic complex disease outcomes by creating a sensitized background for relevant environmental risk factors. Additionally, rare disease communities are motivated research participants, creating the potential of strong research allies among rare Mendelian disease advocacy groups and disease registries and providing a variety of translational opportunities that are under-utilized in genetic or environmental health science.

dc.identifier

6156646

dc.identifier.issn

1096-6080

dc.identifier.issn

1096-0929

dc.identifier.uri

https://hdl.handle.net/10161/22599

dc.language

eng

dc.publisher

Oxford University Press (OUP)

dc.relation.ispartof

Toxicological sciences : an official journal of the Society of Toxicology

dc.relation.isversionof

10.1093/toxsci/kfab022

dc.subject

Cystic Fibrosis

dc.subject

Huntington disease

dc.subject

Parkinson’s disease

dc.subject

Sickle Cell Disease

dc.subject

gene-environment interactions

dc.subject

monogenic Mendelian Diseases

dc.title

The Impact of Environmental Factors on Monogenic Mendelian Diseases.

dc.type

Journal article

pubs.organisational-group

Trinity College of Arts & Sciences

pubs.organisational-group

African & African American Studies

pubs.organisational-group

Biology

pubs.organisational-group

Duke Science & Society

pubs.organisational-group

Duke Global Health Institute

pubs.organisational-group

Family Medicine and Community Health, Community Health

pubs.organisational-group

Duke

pubs.organisational-group

Initiatives

pubs.organisational-group

Institutes and Provost's Academic Units

pubs.organisational-group

University Institutes and Centers

pubs.organisational-group

Family Medicine and Community Health

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

School of Medicine

pubs.publication-status

Published

Files